News

Financing Immune Pharmacy

Like many micro-cap companies, Immune Pharmaceuticals (NASDAQ:IMNP) has had to overcome the challenges of structured financings. Stock price and liquidity are key drivers for an early stage biotech company to raise sufficient capital to advance its pipeline. The good news Read More